◆ 会议时间:2022年4月28-30日
◆ 会议地点:韩国 首尔/Seoul
◆ 会议简介:
2022年第11届世界乳腺癌学术大会暨韩国乳腺癌学术大会(GBCC2022)将于2022年4月28-30日在韩国首尔以线下线下结合形式举行,上届会议有来自70多个国家和地区的12567名代表出席。
全球乳腺癌大会(GBCC)起始于2007年,是在韩国召开的亚洲最大最具影响力的乳腺癌会议之一,会议由韩国乳腺癌学会主办、韩国乳腺癌基金会支持,每年乳腺癌领域的众多专家学者聚集一堂,共同探讨有效诊断和治疗乳腺癌以及提高妇女健康的科学方法;GBCC原为每两年举办一次,自2016年开始,改为每年举办一次。GBCC汇聚了包括医学人士、科研人员、政策制定者、患者和监护人等来自社会各届宣的专业人士,共同探讨多种科学策略,有效地诊断和治疗乳腺癌,促进妇女健康。每届GBCC都有来自世界各地的一千三百余名专业人士与会。——未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。
第11届世界乳腺癌学术大会
11th Global Breast Cancer Conference (GBCC 11)
DATE: April 28 (Thu) – 30 (Sat), 2022
LOCATION: Seoul, Korea
摘要提交:
- Abstract Submission Deadline: February 13 (Sun), 2022, KST
- Notification of Acceptance: March, 2022
- If you would like to withdraw your abstract(s) which have been already submitted, please contact the secretariat via email (gbccabs@intercom.co.kr) February 3 (Thu), 2022.
点此提交摘要>>>Submit Abstract>>>
Abstract Format
- Abstracts should be submitted online in English.
- he abstract structure should be as follows:
- Abstract should be structured into the following headings: Background, Methods, Result, and Conclusion.
- Abstract should not exceed 250 words.
- he maximum number of authors is 30 per abstract.
- igure, Table, Reference and Keyword are not allowed.
- f an author is affiliated with hospital as well as university, please enter the name of the hospital for which he/she works.
Dear Colleagues,
It is our greatest pleasure to draw your attention to the Global Breast Cancer Conference 2022 (GBCC 2022), which will be held from April 28 (Thu) to 30 (Sat), 2022 in Grand Walkerhill Seoul, Korea.
As one of the biggest breast cancer conferences in Asia, the GBCC takes place every year to gather people from all walks of life to come up with multi-scientific strategies to effectively diagnose and treat breast cancer, and ultimately to promote women's health.
GBCC 2022 will be held as a Hybrid Conference (In-person & Virtual) considering all participants’ health and safety as top priority. We will make every effort to render GBCC 2022 remarkably informative and fruitful so that it can be a rewarding experience for all.
We thank you for keen interest in the upcoming GBCC, and we sincerely hope to meet every participants face-to-face in 2022.
Thank you.
GBCC2022 注册费 - Registration Fee:
Category |
In-person |
Virtual |
Early-bird Registration
(2021.11.01 ~ 2022.02.03) |
Pre-registration
(2022.02.04 ~ 2022.03.28) |
On-site Registration
(2022.04.28 ~ 2022.04.30) |
Virtual Registration
(2022.02.04 ~ 2022.03.28) |
Professor / Physician / Company |
Non-member Registration |
USD 500 |
USD 600 |
USD 800 |
USD 500 |
Member Registration 1)
(JBCS, TBCS) |
USD 400 |
USD 480 |
USD 640 |
USD 400 |
Trainee 2) / Nurse / Researcher / Army doctor / Student 2) |
USD 150 |
USD 200 |
USD 250 |
USD 150 |
Survivor 3) |
- |
Refer to item 3) below |
Accompanying Person (Foreigners ONLY) |
USD 150 |
|
Welcome Dinner |
USD 30 |
|
* Fellow/Clinical Instructor: Please register as a Physician category.
* Accompanying Person registration is limited to spouses and can only attend the Opening Ceremony, Exhibition and Welcome Dinner
* Applicants wishing to change their participation from In-person to Virtual after payment, please contact the secretariat.
Member Registration (JBCS, TBCS)
- Registration fee discount of 20% will be applied to the members of below societies.
* Japanese Breast Cancer Society (JBCS)
* Taiwan Breast Cancer Society (TBCS)
- To receive this discount, please register for ‘Member Registration’.
- Please note that the GBCC secretariat will check the authenticity of your membership.
Cancellation Policy
- No refunds will be given after March 28, 2022.
- Cancellation must be notified to the secretariat in writing by e-mail (gbccreg@intercom.co.kr).
- All refunds will be made after the conference for administrative reasons, and all bank service charges and administration fees will be deducted from all conference registration refunds.
- Note that the bank charge for refunds should be paid by the registrants.
Full Refund |
Until March 28 (Mon), 2022 |
No Refund |
After March 28 (Mon), 2022 |
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|